Form 4 for EW Edwards Lifesciences
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-16 · accession 0001225208-25-001908 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | 2025-02-16 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $76.19 | -174 | 30.4K | -0.6% | -$13.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-16 | F | D | 174 | $76.19 | 30,387 | D | — | — |